Porcine RVA (G5P[7], G9P[13]) levels in the small intestine (A) and large intestine (B); RVA shedding (rectal swabs) (C).

Porcine RVA (G5P[7], G9P[13]) levels in the small intestine (A) and large intestine (B); RVA shedding (rectal swabs) (C).

<p>Six-day-old germ-free pigs were orally inoculated with 1 × 106 FFU of each RVA. Swabs were collected at designated time points (day post-infection, dpi, 1-4). For the small and large intestine contents pigs were euthanized at the post-inoculation times indicated and contents were collected....

Saved in:

书目详细资料
主要作者:	Sergei A. Raev (15350287) (author)
其他作者:	Maryssa K. Kick (17183901) (author), Maria Chellis (22683628) (author), Linda J. Saif (6626666) (author), Talita P. Resende (3916268) (author), Anastasia N. Vlasova (6626663) (author)
出版:	2025
主题:	Biophysics Biochemistry Microbiology Ecology Infectious Diseases Space Science Environmental Sciences not elsewhere classified Biological Sciences not elsewhere classified increased sialic acid host characteristics regulate first experimental evidence findings may provide current global dominance rva rna detection multiple extraintestinal organs div >< p rva strains replicated related rva strains porcine osu g5p facilitating viral dissemination efficient extraintestinal spread rva receptor diversity rva extraintestinal spread examined extraintestinal tissues gut </ p extraintestinal tissues extraintestinal spread extraintestinal tissue extraintestinal sites also examined vivo </ vitro </ different tissues well understood respiratory lesions remarkably robust potential role pigs infected moderate titers microscopic lesions intestinal tissue inoculated germ highest titers highest frequency higher rate free pigs determine whether better understand
标签:	添加标签没有标签, 成为第一个标记此记录!

相似书籍

RVA levels in the small intestine (A) and large intestine (B); RVA shedding (rectal swabs) (C).
由: Sergei A. Raev (15350287)
出版: (2025)

Tissue-specific analysis of RVA RNA levels (G5P[7], G9P[13]) in extraintestinal tissues.
由: Sergei A. Raev (15350287)
出版: (2025)

Strain-specific analysis of RVA RNA levels in extraintestinal tissues.
由: Sergei A. Raev (15350287)
出版: (2025)

Strain-specific analysis of RVA RNA levels in extraintestinal tissues.
由: Sergei A. Raev (15350287)
出版: (2025)

Strain-specific analysis of RVA levels (CCIF) in extraintestinal tissues.
由: Sergei A. Raev (15350287)
出版: (2025)

Strain-specific analysis of RVA RNA levels in extraintestinal tissues.
由: Sergei A. Raev (15350287)
出版: (2025)

Strain-specific analysis of RVA RNA levels in extraintestinal tissues.
由: Sergei A. Raev (15350287)
出版: (2025)

Tissue-specific analysis of RVA RNA levels in extraintestinal tissues.
由: Sergei A. Raev (15350287)
出版: (2025)

Spleen (A) and liver (B) with focal positive in situ hybridization signal (brown) for Rotavirus A (G5P[7]).
由: Sergei A. Raev (15350287)
出版: (2025)

Distribution of sialylated and non-sialylated glycans across the intestinal and extraintestinal tissues.
由: Sergei A. Raev (15350287)
出版: (2025)

Lectins and antibodies used in this study.
由: Sergei A. Raev (15350287)
出版: (2025)

The scheme illustrates experimental design.
由: Sergei A. Raev (15350287)
出版: (2025)

Histological changes and positive in situ hybridization signals were observed in germ-free pigs experimentally challenged with Rotavirus A.
由: Sergei A. Raev (15350287)
出版: (2025)

Gross evaluation of extraintestinal organs deteted changes in lungs from germ-free pigs challenged with Rotavirus A.
由: Sergei A. Raev (15350287)
出版: (2025)

All Data Supporting the Findings of This Study.
由: Sergei A. Raev (15350287)
出版: (2025)

Supplementary Tables from Targeting BCL6 in Gastrointestinal Stromal Tumor Promotes p53-Mediated Apoptosis to Enhance the Antitumor Activity of Imatinib
由: Xiangyu Zeng (17314920)
出版: (2025)

Image 7_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tif
由: Elisabeth Damisch (22679276)
出版: (2025)

Data Sheet 1_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.docx
由: Elisabeth Damisch (22679276)
出版: (2025)

Table 1_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.xlsx
由: Elisabeth Damisch (22679276)
出版: (2025)

Image 5_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tiff
由: Elisabeth Damisch (22679276)
出版: (2025)

Image 8_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tiff
由: Elisabeth Damisch (22679276)
出版: (2025)

Image 4_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tiff
由: Elisabeth Damisch (22679276)
出版: (2025)

Image 3_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tiff
由: Elisabeth Damisch (22679276)
出版: (2025)

Image 6_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tiff
由: Elisabeth Damisch (22679276)
出版: (2025)

Image 1_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tiff
由: Elisabeth Damisch (22679276)
出版: (2025)

Image 2_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tiff
由: Elisabeth Damisch (22679276)
出版: (2025)

Supplementary File 1 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
由: Michael P. Ludwig (16721187)
出版: (2025)

Supplementary File 2 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
由: Michael P. Ludwig (16721187)
出版: (2025)

Supplementary File 3 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
由: Michael P. Ludwig (16721187)
出版: (2025)

Supplementary File 4 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
由: Michael P. Ludwig (16721187)
出版: (2025)

Supplementary File 5 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
由: Michael P. Ludwig (16721187)
出版: (2025)

Supplementary File 6 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
由: Michael P. Ludwig (16721187)
出版: (2025)

Supplementary File 7 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
由: Michael P. Ludwig (16721187)
出版: (2025)

Supplementary File 8 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
由: Michael P. Ludwig (16721187)
出版: (2025)

Supplementary Table S3 from Loss of <i>CDKN2A</i> Cooperates with <i>WWTR1(TAZ)–CAMTA1</i> Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma
由: Caleb N. Seavey (15056489)
出版: (2025)

Supplementary Table S4 from Loss of <i>CDKN2A</i> Cooperates with <i>WWTR1(TAZ)–CAMTA1</i> Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma
由: Caleb N. Seavey (15056489)
出版: (2025)

Supplementary Figure 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
由: Tom Wei-Wu Chen (15053003)
出版: (2025)

Supplementary Figure 2 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
由: Tom Wei-Wu Chen (15053003)
出版: (2025)

Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
由: Tom Wei-Wu Chen (15053003)
出版: (2025)

Supplementary Figure 4 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
由: Tom Wei-Wu Chen (15053003)
出版: (2025)

Cannot write session to /tmp/vufind_sessions/sess_egi1e7ph11fv3kisfumbs3o2ib